3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
21
Lung Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Urinary Bladder Neoplasms
12
Ovarian Neoplasms
9
Neoplasm Metastasis
7
Non-Muscle Invasive Bladder Neoplasms
6
Cholangiocarcinoma
6
Triple Negative Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Colorectal Neoplasms
5
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Carcinoma, Transitional Cell
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Bile Duct Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cisplatin
4
Cetuximab
4
cemiplimab
3
Radiotherapy
3
Platinum
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
trastuzumab deruxtecan
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cabozantinib
1
atezolizumab
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Tramadol
1
Taxes
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Gemcitabine
×
30 days
×
Clear all
No trials found.